(89)Zr-DFO-girentuximab PET/CT imaging for clear cell renal cell carcinoma - ZIRCON study results of diagnostic performance, including in very small lesions Meeting Abstract


Authors: Martina, S.; Mulders, P.; Shuch, B. M.; Pantuck, A. J.; Morris, M. A.; Master, V.; Scott, A.; Van Praet, C.; Bailly, C.; Onal, B.; Aksoy, T.; Merkx, R.; Schuster, D. M.; Lee, S.; Pandit-Taskar, N.; Fan, A. C.; Tauchmanova, L.; Schmidt, K.; Allman, P.; Vadali, K.; Hayward, C.; Bernhard, J.
Abstract Title: (89)Zr-DFO-girentuximab PET/CT imaging for clear cell renal cell carcinoma - ZIRCON study results of diagnostic performance, including in very small lesions
Meeting Title: 2023 Annual Congress of the European Association of Nuclear Medicine (EANM'23)
Journal Title: European Journal of Nuclear Medicine and Molecular Imaging
Volume: 50
Issue: Suppl. 1
Meeting Dates: 2023 Sep 9-13
Meeting Location: Vienna,Austria
ISSN: 1619-7070
Publisher: Springer  
Date Published: 2023-09-01
Start Page: S93
End Page: S94
Language: English
ACCESSION: WOS:001084059700192
PROVIDER: wos
DOI: 10.1007/s00259-023-06333-x
PUBMED: 37594496
Notes: Meeting Abstract: OP-194 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors